Med-Metrix Enters Into Definitive Agreement to Acquire Vitalware to Enhance Coding Accuracy and Net Revenue Yield

Med-Metrix, backed by Harvest Partners and A&M Capital Partners, entered a definitive agreement to acquire Vitalware from Health Catalyst (NASDAQ: HCAT).

Rhea-AI Summary

Med-Metrix, backed by Harvest Partners and A&M Capital Partners, entered a definitive agreement to acquire Vitalware from Health Catalyst (NASDAQ: HCAT).

The deal aims to strengthen Med-Metrix's mid-revenue cycle platform, enhancing charge capture, coding accuracy, revenue integrity, and compliance for health system clients, subject to customary closing conditions.

Positive

• Definitive agreement for Med-Metrix to acquire Vitalware from Health Catalyst
• Vitalware enhances Med-Metrix's mid-revenue cycle and revenue integrity capabilities
• Acquisition supports Med-Metrix strategy of combining services with scalable software
• Integration of Vitalware's leadership and employees into Med-Metrix operations
• Vitalware brings 5-Time Best in KLAS chargemaster management platform
• Backers Harvest Partners and A&M Capital Partners supporting the transaction

Negative

• None.

Argus Jun 4 session

+45.86% close to close Open Argus

Details

News Market Reaction – HCAT

In the Jun 4 session, HCAT gained 45.86%, reflecting a significant positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

Market Context

The stock surged +45.9% in the session following this news. A strong positive reaction aligns with h...

Analysis

The stock surged +45.9% in the session following this news. A strong positive reaction aligns with how Health Catalyst’s transaction news has often acted as a catalyst, with prior acquisition announcements averaging a 9.54% move. This divestiture combines a $147 million cash inflow with plans to repay about $160 million of term debt, potentially improving leverage. However, historical patterns also include negative moves on deals, so investors have previously reassessed strategic fit and execution risk after the initial response.

Key Figures

Vitalware sale price: $147 million Vitalware 2025 revenue: $37 million Term loan principal: $160 million +5 more

Vitalware sale price

$147 million

Cash consideration per 8-K Unit Purchase Agreement

Vitalware 2025 revenue

$37 million

Fiscal 2025 revenue for divested business per 8-K

Term loan principal

$160 million

Senior secured term loan principal as of March 31, 2026

Documented outcomes

$2.8 billion

Outcomes cited as foundation for core data and AI offerings

Employee acceptance condition

80%

Selected employees needing to accept offers for deal closing

Shares outstanding

73,894,020

Common shares outstanding as of May 22, 2026 per DEF 14A

Insider sale price

$1.3702 per share

Price for multiple mandated sell-to-cover insider transactions

Founding year

2011

Vitalware founding year noted in article

Previous Acquisition Reports

4 past events · Latest: Jan 13

Same Type 4 events

1. Jan 13

   Acquisition agreement

   24h Move

   -5.8%

   Definitive agreement to acquire Upfront Healthcare Services using cash and stock.

2. Nov 06

   Cybersecurity acquisition

   24h Move

   +7.4%

   Agreement to acquire Intraprise Health to expand cybersecurity and risk offerings.

3. Aug 08

   Care orchestration deal

   24h Move

   +37.8%

   Completion of Lumeon acquisition to enhance care orchestration and analytics.

4. Jun 06

   Oncology tech acquisition

   24h Move

   -1.2%

   Acquisition of Carevive to strengthen oncology care and patient‑reported outcomes.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Key Terms

chargemaster management, revenue integrity, price transparency, mid-revenue cycle

4 terms

chargemaster management financial

"solutions enhance performance across chargemaster management, revenue integrity, price transparency"

Chargemaster management is the process hospitals and health systems use to set, organize and update the official list of prices for procedures, tests and other services — like a detailed menu of charges. It matters to investors because those listed prices influence how much a provider can bill insurers and patients, affect reported revenue, and carry regulatory and reputational risk if prices are inconsistent or noncompliant; think of it as pricing strategy and quality control for a large retailer’s inventory.

revenue integrity financial

"recognized leader in mid-revenue cycle software solutions, with its 5-Time Best in KLAS chargemaster management platform and tools supporting charge capture and regulatory compliance"

Revenue integrity is the set of policies and routine checks that make sure a business, especially in healthcare, accurately records services, bills correctly, and collects the money it is legally owed. Like balancing a household budget and double‑checking bills to avoid missed payments or penalties, it protects cash flow, reduces the risk of audits or fines, preserves profit margins and makes future earnings more predictable for investors.

price transparency financial

"solutions enhance performance across chargemaster management, revenue integrity, price transparency, and coding workflows"

Price transparency is the clear, readily available information about the actual prices, fees and terms buyers and sellers face for a security, product or service. Like seeing price tags on every item in a store, it helps investors compare options, spot hidden costs, judge fairness and make faster decisions; greater transparency tends to lower risk, narrow spreads and improve market efficiency, while opaque pricing raises uncertainty and potential surprises.

mid-revenue cycle financial

"strengthen Med-Metrix's mid-revenue cycle offering, improving charge capture and coding accuracy"

Mid-revenue cycle describes the middle phase of a company’s process for turning sales or services into collected cash—after a sale is recorded but before final payment is received. Think of it as the middle section of a conveyor belt where invoices are prepared, claims are processed and follow-ups happen; its efficiency affects how quickly cash flows into the business and how much working capital or risk of write-offs investors should expect.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

PARSIPPANY, N.J., June 4, 2026 /PRNewswire/ -- Med-Metrix, LLC ("Med-Metrix"), backed by Harvest Partners and A&M Capital Partners, today announced it has entered into a definitive agreement to acquire Vitalware, an industry-leading revenue workflow and analytics software business owned by Health Catalyst (NASDAQ: HCAT). Vitalware's platform and domain expertise will strengthen Med-Metrix's mid-revenue cycle offering, improving charge capture and coding accuracy, which is expected to help drive measurable improvement in net revenue yield for Med-Metrix's clients.

The transaction will augment Med-Metrix's technology-enabled revenue cycle platform and supports its strategy of combining operator-led services with scalable software solutions. Vitalware's leadership team and employees are expected to be integrated into Med-Metrix's operations following the acquisition, further enhancing Med-Metrix's ability to deliver end-to-end solutions across the revenue cycle. The transaction is subject to customary closing conditions.

Vitalware's cloud-based solutions enhance performance across chargemaster management, revenue integrity, price transparency, and coding workflows – critical functions that directly impact reimbursement accuracy and financial performance. The combination will enable Med-Metrix to better support its expanding health system client base in identifying revenue leakage, strengthening compliance, and optimizing net patient revenue.

Founded in 2011 and acquired by Health Catalyst in 2020, Vitalware is a recognized leader in mid-revenue cycle software solutions, with its 5-Time Best in KLAS chargemaster management platform and tools supporting charge capture and regulatory compliance. Its solutions are widely used across hospitals and health systems to improve visibility and continuity in coding, billing, and revenue integrity processes.

"I am very excited to welcome Vitalware to Med-Metrix and build on their strong foundation in revenue integrity," said Joseph Davi, Founder and CEO of Med-Metrix. "This acquisition expands our ability to deliver measurable financial outcomes by combining differentiated technology with deep operational expertise across the mid-revenue cycle."

"Vitalware represents a natural extension of our platform," said Rob Wright, Co-President of Med-Metrix. "By integrating their impressive software capabilities, we are better positioned to help providers improve reimbursement accuracy, manage compliance risk, and capture the full value of care delivered."

"The Vitalware team has built a great business through years of dedication and commitment, and we are grateful for everything they gave to Health Catalyst," said Ben Albert, CEO of Health Catalyst. "This strategic move opens our next phase, and we have found a tremendous partner in Med-Metrix to take Vitalware forward."

"We are pleased to support Med-Metrix in this strategic acquisition," said Lucas Rogers, Partner at Harvest Partners. "Vitalware will enhance the Company's mid-revenue cycle capabilities, positioning Med-Metrix to continue executing on its growth strategy through a combination of organic initiatives and targeted acquisitions."

About Med-Metrix

Med-Metrix is a leading technology-enabled services platform providing end-to-end Revenue Cycle Management (RCM) and Business Intelligence solutions for health systems and physician groups across the United States. The Company combines proprietary technology with deep operational expertise to drive measurable financial and operational outcomes.

About Vitalware

Vitalware provides cloud-based software solutions focused on revenue integrity, chargemaster management, pricing transparency, and coding optimization. Its platform helps healthcare organizations improve compliance, enhance charge capture, and optimize financial performance across the mid-revenue cycle. Founded in 2011, Vitalware was acquired by Health Catalyst in 2020 and has been widely adopted by hospitals and health systems nationwide.

About Harvest Partners

Founded in 1981, Harvest Partners is an established private equity firm with over 40 years of experience investing in middle-market companies and partnering with high-quality management teams to build growing businesses. The firm invests in service-oriented business across four core sectors: business services & industrials, commercial services, consumer services and healthcare services. This strategy leverages Harvest Partners' multi-decade experience in financing organic and acquisition-oriented growth opportunities. The firm has ~$20 billion in assets under management as of December 31, 2025. For more information, please visit www.harvestpartners.com.

View original content to download multimedia:https://www.prnewswire.com/news-releases/med-metrix-enters-into-definitive-agreement-to-acquire-vitalware-to-enhance-coding-accuracy-and-net-revenue-yield-302791688.html

SOURCE Med-Metrix, LLC

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What is Med-Metrix acquiring from Health Catalyst (NASDAQ: HCAT) in June 2026?

Med-Metrix signed a definitive agreement to acquire Vitalware, Health Catalyst's revenue workflow and analytics software business. According to Health Catalyst, Vitalware focuses on chargemaster management, revenue integrity, price transparency, and coding workflows used by hospitals and health systems to improve reimbursement accuracy and financial performance.

How will the Vitalware acquisition affect Med-Metrix's revenue cycle platform?

The acquisition is expected to expand Med-Metrix's mid-revenue cycle offering and technology-enabled revenue cycle platform. According to the companies, Vitalware should help improve charge capture, coding accuracy, compliance, and net patient revenue optimization for Med-Metrix's health system clients across the revenue cycle.

What happens to Vitalware's leadership and employees after the Med-Metrix acquisition?

Vitalware's leadership team and employees are expected to be integrated into Med-Metrix operations. According to the announcement, this integration is intended to enhance Med-Metrix's ability to deliver end-to-end revenue cycle solutions by combining operator-led services with Vitalware's established software capabilities.

Why is Med-Metrix interested in acquiring Vitalware from Health Catalyst (HCAT)?

Med-Metrix views Vitalware as a natural extension of its platform, strengthening mid-revenue cycle and revenue integrity services. According to company leaders, combining Vitalware’s software with Med-Metrix’s operational expertise aims to improve reimbursement accuracy, manage compliance risk, and capture the full value of delivered care.

What capabilities does Vitalware add to Med-Metrix's mid-revenue cycle services?

Vitalware contributes cloud-based tools for chargemaster management, revenue integrity, price transparency, and coding workflows. According to the companies, these capabilities directly support reimbursement accuracy, regulatory compliance, and identification of revenue leakage across hospital and health system billing and revenue integrity processes.

Is the Med-Metrix acquisition of Vitalware from Health Catalyst already closed?

No, the acquisition has not yet closed and remains subject to customary closing conditions. According to the companies, Vitalware will be integrated into Med-Metrix operations following completion, with its leadership and employees expected to join Med-Metrix as part of the transaction.